Aspira Women's Health Inc. DEF 14A Filing
Ticker: AWHL · Form: DEF 14A · Filed: Apr 11, 2025 · CIK: 926617
Sentiment: neutral
Topics: executive-compensation, board-of-directors, sec-filing, corporate-governance
Related Tickers: AWH
TL;DR
Aspira Women's Health Inc. filed its DEF 14A, showing exec comp for 2024. Board members like Sandra Milligan and Nicole Sandford are listed.
AI Summary
Aspira Women's Health Inc. filed a DEF 14A on April 11, 2025, detailing executive compensation and board member information for the fiscal year ending December 31, 2024. The filing includes compensation details for Sandra Milligan and Nicole Sandford, among others, and reports on equity awards granted during the 2024 fiscal year.
Why It Matters
This filing provides transparency into the compensation packages of Aspira Women's Health Inc.'s top executives and board members, which can influence investor decisions and corporate governance evaluations.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of executive compensation and board information, not indicating any immediate financial distress or significant operational changes.
Key Players & Entities
- Aspira Women's Health Inc. (company) — Filer of the DEF 14A
- Sandra Milligan (person) — Board Member and recipient of equity awards
- Nicole Sandford (person) — Board Member
- 2024-12-31 (date) — Fiscal year end for reported compensation
- 20250411 (date) — Filing date of the DEF 14A
FAQ
What is the primary purpose of this DEF 14A filing for Aspira Women's Health Inc.?
The primary purpose is to disclose information regarding executive compensation, board member details, and other corporate governance matters for the fiscal year ending December 31, 2024.
Who are the key individuals whose compensation is detailed in this filing?
Key individuals include board members such as Sandra Milligan and Nicole Sandford, along with other executive and non-executive board members.
What period does the compensation information in this filing cover?
The compensation information primarily covers the fiscal year ending December 31, 2024, with some comparative data from previous years.
What type of awards are mentioned in relation to Sandra Milligan?
Equity awards are mentioned in relation to Sandra Milligan, specifically as a reported value of equity awards for the 2024 fiscal year.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on April 11, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 11, 2025 by Sandra Milligan regarding Aspira Women's Health Inc. (AWHL).